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Regional anaesthesia in cancer surgery:  
an  update
Abstract
Anaesthetic techniques can influence the cellular immune system and 
affect long term outcome. Cancer surgery itself and general anaesthetics, 
especially opioids, suppress immunity and therefore promote metastases. Re-
gional anaesthesia attenuates the immunosuppressive effect of surgery. Local 
anaesthetics, contrary to opioids, stimulate the activity of natural killer (NK) 
cells during the perioperative period. All techniques of regional anaesthesia 
are very useful and applicable in cancer surgery, either for the anaesthesia 
itself or for the treatment of postoperative pain. The relationship between 
regional anaesthesia and cancer recurrence is one of the most interesting 
topics in anaesthesia today, but we must wait the results of prospective trials 
before definitive conclusions. 
 
INTRODUCTION
Cancer remains a significant cause of morbidity and mortality inter-nationally. It is the second most common cause of death. The like-
lihood of tumour metastases depends on the balance between the 
metastatic potential of the tumour and the anti-metastatic host defenc-
es. Surgery is the mainstay treatment for solid tumours, but studies on 
humans have demonstrated that surgery itself can promote the develop-
ment of metastases. The potential effect of anaesthesia on long-term 
patient outcome has been increasingly acknowledged (1). The periop-
erative period is a critical time and the suppression of host defence 
mechanisms at that time can have deleterious long-term consequences. 
The perioperative stress response affects the immune system which has 
been developed to protect us from infection but also from cancer. There-
fore, at the same time cancer surgery may initiate migration of cancer 
cells through the body and supress the defence immune system. The 
question that arises is how the choice of anaesthetic technique improves 
ability of body to eliminate cancer cells and upgrade survival.
PERIOPERATIVE IMMUNE RESPONSE AND 
CANCER
Animal studies indicate that immune response control over the cir-
culation of tumour cells and micrometastasis is carried out mainly 
through cell-mediated immunity (CMI), which includes cytotoxic T 
lymphocytes, NK (natural killer) cells, NK-T cells, dendritic cells and 
macrophages (2). NK cells are important because they can naturally 
recognise and kill malignant cells. B-adrenergic stimulation, which in-
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metastasis (3). Human studies show that low periopera-
tive levels of NK activity are associated with an increased 
cancer related morbidity and mortality (4, 5). 
Cancer surgery supresses immunity and therefore pro-
motes metastasis. Growth of pre-existing micro metasta-
ses and dissemination of malignant cells during postop-
erative period is facilitated (6). Further, surgical stress 
activates angiogenesis which contributes to neoplastic 
growth. 
ROLE OF ANAESTESIA IN THE 
PEROPERATIVE IMMUNE RESPONSE 
AND CANCER
The choice of anaesthetic technique and drugs pro-
foundly influences the immune response and consequent-
ly cancer metastasis. Melamed et al. demonstrated in rats 
that ketamine, thiopental and halothane reduces NK cell 
activity and increased lung tumour retention or lung me-
tastasis (7). Propofol does not affect metastasis, which 
may be related to its B-adrenergic antagonist properties 
(8). Another study has been looked at propofol conjugates 
(propofol-docosahex-aenoate and propofol-eicosapentae-
noate) as treatment for breast cancer, as they have been 
shown to inhibit cellular adhesion, migration and apop-
tosis in breast cancer cells. Effects of inhalation anaesthet-
ics on tumour growth were studied by Brozovic et al. in 
mice. Their results confirmed the genotoxic and cyto-
toxic activity of halogenated inhalation anaesthetics on 
tumour cells (9). Isoflurane and halothane inhibit inter-
feron stimulation of NK cell cytotoxicity in mice (10). 
Multiple studies have demonstrated in vitro effects that 
may have some relevance in the cancer setting. For in-
stance, sevoflurane alters the release of cytokines (IL-1b 
and TNF-a, but not IL-2) by NK and NK-like cells in 
vitro (11). In humans, one large retrospective analysis 
found that general anaesthesia for excision of primary 
melanoma was associated with a decrease in the survival 
rate compared with local anaesthesia. The difference was 
attributed to use of general anaesthetic agents. General 
anaesthesia decreases circulating NK cells in patients un-
dergoing elective orthopaedic surgery (12). Neutrophil, 
macrophage, dendritic and T-cell function are also im-
paired (13). Nitrous oxide interferes with DNA, purine 
and thymidylate synthesis and depressed neutrophil che-
motaxis (14). Opioid administration has been shown to 
suppress cell-mediated and humoral immunity. This in-
cludes NK cell activity, production of immune-stimulat-
ing cytokines, phagocytic activity and antibody produc-
tion (13, 15). Morphine at clinically relevant doses 
increases angiogenesis and promotes breast tumour 
growth in mice (16). Tramadol, which has noradrenergic 
and serotonergic activity, stimulates NK cell activity, both 
in rodents and humans (17). The differences between 
morphine and tramadol have been shown in humans un-
dergoing hysterectomy for uterine carcinoma. T-lympho-
cyte proliferation was depressed in both groups, but re-
mained depressed only in morphine group. Neither 
surgery nor morphine affected NK cell activity, whereas 
tramadol was shown to enhance NK cell activity. Long 
term outcome was not reported (18).
Non-steroidal anti-inflammatory drugs inhibit prosta-
glandin synthesis via inhibition of the cyclooxygenase 
(COX) enzyme. Tumour cells have been shown to secrete 
prostaglandins, and this may be a mechanism to evade 
host cell-mediated immunity (19).
When we analyse the effects of regional anaesthesia, 
we can find two major retrospective studies. One showed 
a 57% reduction in incidence of biochemical cancer re-
currence when epidural analgesia was used for open pros-
tatectomy when compared with postoperative opioid 
analgesia. The other showed a four-fold reduction in the 
incidence of recurrence or metastasis in patients who re-
ceived general and paravertebral anaesthesia and analgesia 
when compared with general anaesthesia and morphine 
analgesia for breast cancer surgery (20). The effect of re-
gional anaesthesia on human breast cancer cells in vitro 
has also been investigated. Serum from patients who re-
ceived propofol/ paravertebral anaesthesia was found to 
inhibit proliferation but not migration of an oestrogen 
receptor-negative breast cancer cell line when compared 
with a sevoflurane/ opioid group (21).
The potential ability of regional anaesthesia to improve 
long-term outcome after cancer surgery can be attributed 
to at least three different mechanisms. First, regional an-
aesthesia attenuates the immunosuppressive effect of sur-
gery. Secondly, patients who received regional analgesia 
have lower opioid requirements. Opioids may themselves 
inhibit cell-mediated immunity and host anti-tumour 
defences. Finally, when regional anaesthesia is used in 
addition to general anaesthesia, the amount of general 
anaesthetic required during surgery is reduced. Further, 
local anaesthetics contrary to opioids stimulate the activ-
ity of NK cells during the perioperative period. Intrave-
nous infusion of lidocaine reduces surgery-induced im-
mune alterations. The long-term clinical implications of 
these findings are unknown and warrant future investiga-
tions (13). Acute pain suppressed NK cell activity too. 
Optimizing postoperative pain management may attenu-
ate the post-surgical inhibition of host anti-tumour de-
fence mechanism, including NK cells.
Postoperative pain therapy may play a very important 
role in metastasis after cancer surgery. Page et al. demon-
strated in rats that the provision of pain relief attenuates 
the surgery-induced increase in metastatic susceptibility, 
likely because of reduction in the stress response. They 
demonstrated that preoperative intrathecal administra-
tion of bupivacaine plus morphine and the perioperative 
systemic administration of fentanyl significantly en-
hanced the host resistance to surgery-induced increases in 
lung metastasis. They suggested that the pain-alleviating 
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effect of these drugs attenuated the surgery-induced pro-
motion of metastasis rather than having direct effect on 
immunity, tumour cells or other mechanisms (22). 
Opioids likely play a profoundly negative role. Mor-
phine has been repeatedly shown to promote angiogene-
sis. It is well established that opioids inhibit cellular and 
humoral immune function in humans.
Anaesthetic strategies that protect the immune system 
have been suggested to guard against this effect and may 
reduce cancer recurrence and improve length of survival. 
Regional anaesthesia has been shown to minimise im-
munosuppression via its opioid sparing effect and by re-
ducing the response to surgical stress. 
There are many conflicting studies regarding regional 
anaesthesia and its impact on cancer recurrence. It has 
been reported that regional anaesthesia decreases some of 
the risk factors that promote cancer metastasis by attenu-
ating the neuroendocrine stress response to surgery, re-
ducing pain, the need for general anaesthetics, minimiz-
ing opioid use and decreasing pro-inf lammatory 
cytokines. The theory is that regional anaesthesia may 
leave an intact immune system which could potentially 
decrease cancer recurrence via endogenous removal of 
tumour cell microemboli. A large analysis of 42 000 pa-
tients with colon cancer who underwent colon resection 
demonstrated that epidural use was associated with 5-year 
improved overall survival, but not actual cancer recur-
rence (23). 
However, more prospective randomised controlled 
clinical trials are necessary to statistically demonstrate a 
causal relationship between regional anaesthesia and can-
cer recurrence. In general, all techniques of regional an-
aesthesia are very useful and applicable in cancer surgery, 
either for the anaesthesia itself or for the treatment of 
postoperative pain. We previously mentioned the benefits 
of thoracic paravertebral block for breast surgery and its 
influence on the cancer recurrence. However, this tech-
nique has the potential to offer long-lasting pain relief and 
reduce postoperative nausea, vomiting and chronic pain. 
Paravertebral block can uniquely eliminate cortical re-
sponses to thoracic dermatomes stimulation (24).  
The results of studies aimed on application of epidural 
anaesthesia (EA) in large abdominal surgery are contro-
versial. Although EA is theoretically supposed to be a 
favourable immune-modulating intervention, not all 
studies show a consistent beneficial effect from EA in co-
lon cancer patients. There is increasing evidence deriving 
from animal studies thoracic epidural blockade could 
have an important role in modifying tissue microperfu-
sion and protecting microcirculatory weak units from 
ischemic damage, regardless of the effect on macro-hae-
modynamics. Continuous EA is a technique that ensures 
quality analgesia for surgery in the upper abdomen. Its 
advantages are reduction of opioid consumption, lower 
incidence of cardiac and pulmonary complications, short-
er duration of postoperative ileus and early mobilisation 
of patients (25). Christopherson et al. found a better over-
all survival in the first 1.5 post-operative years in 177 
colon cancer patients for stage I-II patients with a mean 
age of 69 years old who received EA. Nevertheless, the 
type of anaesthesia did not appear to affect long-term 
survival (26). A significant better overall survival was 
found by Holler et al. The positive impact of this study 
was the most significant in the high-risk patients (Amer-
ican Society of Anesthesiologists (ASA) score 3-4) (27). 
The Swedish study of Gupta et al. found a reduction in 
all-cause mortality in rectal cancer patients who received 
EA (28). Contrary, the study of Myles et al. suggested that 
the use of epidural block in abdominal surgery for cancer 
is not associated with improved cancer-free survival (29). 
Study of Hiller et al. considered that effective epidural 
analgesia improves cancer outcomes following gastro-
oesophageal cancer surgery in patients with grouped 
pathological staging (30). Continuous EA is a technique 
that ensures quality analgesia for surgery in the upper 
abdomen. The advantages of EA are reduced opioid con-
sumption, lower incidence of cardiac and pulmonary 
complications, and shorter duration of postoperative ileus 
and early mobilisation of patients. However, there are 
some limitations in the use of EA in the liver surgery such 
as postoperative coagulation disorders. 
Contrary to EA continuous wound infiltration (CWI) 
is analgesic technique of application local anaesthetic di-
rectly into surgical wound through multi-holed wound 
catheter placed by surgeon on the end of the surgery. 
CWI enables reduction in opioid consumption and opi-
oid related side effects, earlier recovery of bowel function 
and hospital stay. Continuous wound infusion of local 
anaesthetics has been successfully applied for postopera-
tive pain control in several procedures but, it is underused 
in thoracic surgery. Fiorelli et al. in their paper concluded 
that CWI is an effective, easy and safe procedure. It sig-
nificantly reduces systemic inflammatory markers, pain 
scores and opioid intake; and accelerates the recovery of 
respiratory function (31).
In ovarian cancer patients intraoperative use of epidu-
ral anaesthesia was associated with an increased time to 
tumour recurrence after surgery (32). Quality improve-
ment in colorectal and gynaecological surgery is perform-
ing the transversus abdominis plane (TAP) block. Adding 
TAP block is appropriate tool to improve patient and fi-
nancial outcomes and to achieve better results of treat-
ment. Keller and colleges analysed results of 200 patients 
with colorectal carcinoma and concluded that transverses 
abdominis plane blocks may be an efficient, cost-effective 
method for improving laparoscopic colorectal surgery 
(33). 
Peripheral nerve blocks (PNB) or plexus blocks can be 
used when pain occurs in the area of one or more periph-
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eral nerves. The pain may arise from primary or secondary 
tumor deposits or be the result of treatment or secondary 
complications such as pathological fracture or vascular 
occlusion. PNB are often used to avoid side effects and 
complications of general anaesthesia, particularly respira-
tory-related effects, and to provide analgesia while mini-
mizing opioid use. PNB are widely-used for surgical an-
aesthesia as well as for postoperative pain control, and 
offer distinct benefits over general or central blocks in 
certain clinical situations. Further, PNB provide analgesia 
that may be superior to other techniques for some pa-
tients. Koshy et al. described successful continuous femo-
ral block for pain relief of acute severe cancer related pain 
caused by pathological femur fracture (34). Locoregional 
anaesthesia provides better pain control, eliminating the 
need for opioids in the postoperative period and resulting 
in negative effects on immune function and tumour 
growth; it also reduces the release of endogenous opioids 
(35).
CONCLUSION
Finally, we could conclude that the relationship be-
tween regional anaesthesia and cancer recurrence is one 
of the most interesting topics in anaesthesia today. The 
concept that anaesthesia can influence the outcome of 
cancer would raise our speciality to a new level. We must 
wait the results of prospective trials before definitive con-
clusions. 
REFERENCES
 1.  SNYDER G L, GREENBERG S 2010 Effect of anaesthetic tech-
nique and other perioperative factors on cancer recurrence. Br J 
Anaesth 105: 106-15
 2.  SMYTH M J, GODFREY D I, TRAPANI J A 2001 A fresh look 
at tumor immunosurveillance and immunotherapy. Nat Immunol 
2: 293-9
 3.  SHAKHAR G, BEN-ELIYAHU S 1998 In vivo beta-adrenergic 
stimulation suppresses natural killer activity and compromises 
resistance to tumor metastasis in rats. J Immunol 160: 3251-8
 4.  BRITTENDEN J, HEYS S D, ROSS J, EREMIN O 1996 Natu-
ral killer cells and cancer. Cancer 77: 1226-43
 5.  LEVY S M, HERBERMAN R B MALUISH A M, SCHLIEN B, 
LIPPMAN M 1985 Prognostic risk assessment in primary breast 
cancer by behavioral and immunological parameters. Health Psy-
chol 4: 99-113
 6.  BEN-ELIYAHU S 2003 The promotion of tumor metastasis by 
surgery and stress: immunological basis and implications for psy-
choneuroimmunology. Brain Behav Immun 17 (Suppl 1): S27-36
 7.  MELAMED R, BAR-YOSEF S, SHAKHAR G, SHAKHAR K, 
BEN-ELIYAHU S 2003 Suppression of natural killer cell activity 
and promotion of tumor metastasis by ketamine, thiopental, and 
halothane, but not by propofol: mediating mechanisms and prop-
hylactic measures. Anesth Analg 97: 1331-9
 8.  ZHOU W, FONTENOT H J, WANG S N, KENNEDY R H 
1999 Propofol-induced alterations in myocardial beta-adrenocep-
tor binding and responsiveness. Anesth Analg 89: 604-8
 9.  BROZOVIC G, ORSOLIC N, KNEZEVIC F, HORVAT KN-
EZEVIC A, BENKOVIC V, SAKIC K, HRGOVIC Z, BEND-
ELJA K, FASSBENDER W J 2009 Genotoxicity and cytotoxicity 
of cisplatin treatment combined with anaesthetics on EAT cells in 
vivo. Onkologie 32: 337-43
10.  MARKOVIC S N, KNIGHT P R, MURASKO D M 1993 Inhi-
bition of interferon stimulation of natural killer cell activity in mice 
anesthetized with halothane or isoflurane. Anesthesiology 78: 700-
6
11.  MITSUHATA H, SHIMIZU R, YOKOYAMA M M 1995 Sup-
pressive effects of volatile anesthetics on cytokine release in human 
peripheral blood mononuclear cells. Int J Immunopharmacol 17: 
529-34
12.  BRAND J M, KIRCHNER H, POPPE C, SCHMUCKER P 
1997 The effects of general anesthesia on human peripheral im-
mune cell distribution and cytokine production. Clin Immunol 
Immunopathol 83: 190-4
13.  SESSLER D I 2008 Does regional analgesia reduce the risk of 
cancer recurrence? A hypothesis. Eur J Cancer Prev 17: 269-72
14.  WEIMANN J 2003 Toxicity of nitrous oxide. Best Pract Res 17: 
47-61
15.  VALLEJO R, DE LEON-CASASOLA O, BENYAMIN R 2004 
Opioid therapy and immunosuppression: a review. Am J Ther 11: 
354-65
16.  GUPTA K, KSHIRSAGAR S, CHANG L, SCHWARTZ R, 
LAW P Y, YEE D, HEBBEL R P 2002 Morphine stimulates an-
giogenesis by activating proangiogenic and survival-promoting 
signaling and promotes breast tumor growth. Cancer Res 62: 4491-
8
17.  GASPANI L, BIANCHI M, LIMIROLI E, PANERAI AE, SAC-
ERDOTE P 2002 The analgesic drug tramadol prevents the effect 
of surgery on natural killer cell activity and metastatic colonization 
in rats. J Neuroimmunol 129: 18-24 
18.  SACERDOTE P, BIANCHI M, GASPANI L, MANFREDI B, 
MAUCIONE A, TERNO G, AMMATUNA M, PANERAI A E 
2000 The effects of tramadol and morphine on immune responses 
and pain after surgery in cancer patients. Anesth Analg 90: 1411-4
19.  WOJTOWICZ-PRAGA S 2003 Reversal of tumor-induced im-
munosuppression by TGF-beta inhibitors. Invest New Drugs 21: 
21-32
20.  BIKI B, MASCHA E, MORIARTY D C, FITZPATRICK J M, 
SESSLER D I, BUGGY D J 2008 Anesthetic technique for radical 
prostatectomy surgery affects cancer recurrence: a retrospective 
analysis. Anesthesiology 109: 180-7
21.  COLOZZA M, AZAMBUJA E, CARDOSO F, SOTIRIOU C, 
LARSIMONT D, PICCART MJ 2005 Proliferative markers as 
prognostic and predictive tools in early breast cancer: where are we 
now? Ann Oncol 16: 1723-39
22.  PAGE G G, BLAKELY W P, BEN-ELIYAHU S 2001Evidence 
that postoperative pain is a mediator of the tumor-promoting ef-
fects of surgery in rats. Pain 90: 191-9
23.  CUMMINGS K C 3RD, XU F, CUMMINGS L C, COOPER G 
S 2012 A comparison of epidural analgesia and traditional pain 
management effects on survival and cancer recurrence after colec-
tomy: a population-based study. Anesthesiology 116: 797-806
24.  KLEIN S M, BERGH A, STEELE S M, GEORGIADE G S, 
GREENGRASS RA 2000 Thoracic paravertebral block for breast 
surgery. Anesth Analg 90: 1402-5
25.  ŠTEFANČIĆ L J, BROZOVIĆ G, ŠTURM D, MALDINI B, 
ŠAKIĆ ZDRAVČEVIĆ K 2013 Continuous wound infusion ver-
sus epidural postoperative analgesia after liver resection in carci-
noma patients. Period biol 115: 191-195
26.  CHRISTOPHERSON R, JAMES K E, TABLEMAN M, MAR-
SHALL P, JOHNSON F E 2008 Long-term survival after colon 
cancer surgery: a variation associated with choice of anesthesia. 
Anesth Analg 107: 325-32
Regional anaesthesia and cancer Gordana Brozović et al.
Period biol, Vol 117, No 2, 2015. 223
27.  HOLLER J P, AHLBRANDT J, BURKHARDT E, GRUSS M, 
RÖHRIG R, KNAPHEIDE J, HECKER A, PADBERG W, 
WEIGAND M A 2013Peridural analgesia may affect long-term 
survival in patients with colorectal cancer after surgery (PACO-
RAS-Study): an analysis of a cancer registry. Ann Surg 258: 989-93
28.  GUPTA A, BJÖRNSSON A, FREDRIKSSON M, HALLBÖÖK 
O, EINTREI C 2011 Reduction in mortality after epidural anaes-
thesia and analgesia in patients undergoing rectal but not colonic 
cancer surgery: a retrospective analysis of data from 655 patients 
in central Sweden. Br J Anaesth 107: 164-70
29.  MYLES P S, PEYTON P, SILBERT B, HUNT J, RIGG J R, 
SESSLER D I, ANZCA TRIALS GROUP INVESTIGATORS 
2011 Perioperative epidural analgesia for major abdominal surgery 
for cancer and recurrence-free survival: randomised trial. BMJ 342: 
d1491 doi: 10.1136/bmj.d1491.
30.  HILLER J G, HACKING M B, LINK E K, WESSELS K L, RIE-
DEL B J 2014 Perioperative epidural analgesia reduces cancer re-
currence after gastro-oesophageal surgery. Acta Anaesthesiol Scand 
58: 281-90
31.  FIORELLI A, IZZO A C, FRONGILLO E M, DEL PRETE A, 
LIGUORI G, COSTANZO E D, VICIDOMINI G, SANTINI 
M 2015 Efficacy of wound analgesia for controlling post-thoracot-
omy pain: a randomized double-blind study. Eur J Cardiothorac 
Surg, Mar 11. pii: ezv097. [Epub ahead of print]
32.  DE OLIVEIRA G S JR, AHMAD S, SCHINK J C, SINGH D 
K, FITZGERALD P C, MCCARTHY R J 2011 Intraoperative 
neuraxial anesthesia but not postoperative neuraxial analgesia is 
associated with increased relapse-free survival in ovarian cancer 
patients after primary cytoreductive surgery. Reg Anesth Pain Med 
36: 271-7
33.  KELLER D S, ERMLICH B O, DELANEY C P 2014 Demon-
strating the benefits of transversus abdominis plane blocks on pa-
tient outcomes in laparoscopic colorectal surgery: review of 200 
consecutive cases. J Am Coll Surg 219: 1143-8
34.  KOSHY R C, PADMAKUMAR G, RAJASREE O 2010 Low cost 
continuous femoral nerve block for relief of acute severe cancer 
related pain due to pathological fracture femur. Indian J Palliat 
Care 16: 180-2
35.  FODALE V, D’ARRIGO M G, TRIOLO S, MONDELLO S, LA 
TORRE D 2014 Anesthetic techniques and cancer recurrence af-
ter surgery. Scientific World Journal 2014:328513. doi: 
10.1155/2014/328513. eCollection 2014
